Friday, May 12, 2023 1:45 PM – 2:30 PM ET Exhibit Hall D, Room 3
Exhibitor Workshop: Alamar Biosciences
Expanding the Limits of Immune Profiling with Automated, Highly-Sensitive, Multiplexed Analysis
- Alex Forrest-Hay, VP of Sales, Introducing NULISA™ and the ARGO™ System, a Fully-Automated, Ultra-high Sensitivity Platform for Liquid-based Protein Analysis
- Xiao-Jun Ma, Ph.D., Chief Technology Officer, Highly-Sensitive and Robust Protein Analysis with 200-plex NULISAseq™ Inflammation Panel
- Susanne Schmidt, PhD, Principal Investigator, University Hospital Bonn, Activation and functional modulation of myeloid cells in SARS‐CoV‐2 infection
Alamar Biosciences provides automated, high-throughput solutions for high sensitivity protein analysis and multiplex capability. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard ELISA or PEA approaches. The NULISA Immuno-Inflammation Panel contains over 200 important markers of immune response enabling comprehensive analysis of immune and inflammatory disease s. The ARGO™ Platform provides a fully-automated workflow with fewer than 30 minutes hands-on time from sample to data, enabling highly reproducible results with CV’s of less than 10%. With both qPCR and NGS readouts, the ARGO™ System enables both focused analysis of validated biomarkers to highly multiplexed profiling of hundreds to ultimately thousands of proteins. This workshop will present data describing the performance of Argo™ system and NULISA™ Assays for cytokine analysis in plasma samples, and demonstrate superior sensitivity and lower limits of detection in comparison to other commercially-available solutions.